Despite improvements and advances in diagnostic and therapeutic strategies, colon cancer remains the leading cause of cancer-related deaths worldwide (Siegel et al.
2018; Chaffer and Weinberg
2011). Most of these deaths are caused by metastatic diseases (Dong et al.
2019). Surgical resection is the first line of treatment for colon cancer (Li et al.
2019). Most of patients have metastasized during the diagnosis, making surgical resection ineffective. There is no significant improvement in the 5-year survival rate and risk of recurrence in colon cancer patients due to local recurrence and tumor metastasis. Therefore, a deeper understanding of the molecular and cellular basis of metastasis is of high clinical significance (Rokavec et al.
2017). Increasing evidence suggests that many molecular expression changes are involved in signal transduction pathways in colon cancer metastasis by affecting key molecular targets (Zhou et al.
2017; Zykova et al.
2018). Therefore, the identification of key molecular targets is of significant value for the diagnosis and treatment of patients with metastatic colon cancer. In this study, we analyzed a novel mechanically activated ion-channel Piezo1, as a potential molecular target for metastatic colon cancer.
Malignant tumor cells are characterized by migration, invasion, and metastasis (Chubinskiy-Nadezhdin et al.
2019). Tumor cell mobility is affected by a variety of signaling cascades, including ion channels and transporters (Schwab and Stock
2014). Mechanically sensitive calcium-permeable ion channels are mainly involved in the process of cell movement (Chaffer and Weinberg
2011). Mechanically sensitive channels can regulate calcium-dependent signaling cascades associated with tumor cell migration by promoting local calcium influx (Maroto and Hamill
2007). Piezo1, also known as FAM38A, is a member of PIEZO family (including Piezo1 and Piezo2). Coste B et al. first proposed that the Piezo1 protein is a component of a mechanically activated cation channel (Coste et al.
2010,
2012), which directly senses mechanical forces and converts environmental signals into intracellular Ca
2+ responses (Miyamoto et al.
2014). In addition, Piezo1 has been confirmed to be a cell stretch sensor that integrates physiological forces into vascular structures and is involved in vascular development and function (Li et al.
2014; Ranade et al.
2014). Piezo1 is widely expressed in a variety of cells and tissues, including tumor cells (Liu et al.
2018). Recent research has showed that Piezo1 is involved in TFF1-mediated gastric cancer cell migration (Yang et al.
2014). Furthermore, Piezo1 activated by agonist Yoda1 could promote TRAIL-mediated cell apoptosis via mitochondrial outer membrane permeability (Hope et al.
2019). Except Piezo1, MCU, an evolutionarily conserved Ca
2+ channel, has been found, which plays a role in regulating intracellular Ca
2+ signaling for mitochondria (Cui et al.
2017; Ren et al.
2017). HIF-1α, a Ca
2+-sensitive factor, has been confirmed to be involved in tumor cell metastasis by promoting EMT (Chen et al.
2017). Although Piezo1 has been extensively studied after being confirmed as a mechanical sensor, functional research of this protein is still limited. Therefore, in our study, we explored the regulatory relationships among Piezo1, MCU, and HIF-1α in colon cancer metastasis.
The role of Piezo1 in colon cancer metastasis remains largely unknown. In this study, we provided evidence that Piezo1 was associated with tumor metastasis in colon cancer patients. The expression of Piezo1 was elevated in colon cancer tissues, and the expression of Piezo1 was a prognostic factor for colon cancer patients. Overexpression of Piezo1 promoted colon cancer cell viability, migration, and metastasis. Moreover, we hypothesized Piezo1-MCU-HIF-1α-VEGF axis, a potential regulatory mechanism in colon cancer metastasis.